Retinal Realities Podcast – Episode 24 – Rare Retinal Diseases
π Rare Disease Day 2025 – Shining a Light on Rare Retinal Diseases! π
This Rare Disease Day (28 Feb 2025), Retina South Africa highlights the challenges and breakthroughs in rare retinal diseases with expert Claudette Medefindt on our latest podcast episode! ποΈ
π Did you know? ποΈ Rare retinal diseases affect fewer than 1 in 10,000 people. π§¬Genetic testing is key to accurate diagnosis, with over 300 genes linked to these conditions. π‘Exciting advancements like gene therapy & CRISPR bring hope for future treatments!
π Managing life with a rare retinal disease? Prioritize healthy living, screen breaks, and expert guidanceβand remember, you’re not alone! Retina SA is here to support you.
Listen on Spotify https://spoti.fi/3EWa7Dn
Listen on YouTube: https://youtu.be/VFQvmfHNHK8
Thank you to Roche Products (Pty) Ltd for sponsoring this wonderful series of Retinal Realities podcasts.
Podcast Disclaimer: Any information, either audio or visual, contained on this Podcast is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
We are not medical doctors, and you should always contact your physician or other qualified health care professional for any medical advice you need.
The views expressed in this podcast do not reflect the views of Retina South Africa or any of our sponsors.
More Articles
Article title: Retinal Realities Podcast – Episode 30 – Defying Diabetes .
November marked both Diabetes Awareness Month and Disability Awareness Month. To reflect on these important observances, Retinal Realities brings.
Article title: Retinal Realities Podcast – Episode 29 – Redefining Independence .
In Episode 29 of Retinal Realities, host Claudette Medefindt sits down with Caryl Baum β a retired lawyer, mother,.
Article title: Retinal Realities Podcast Episode 23 – Pedalling Through Challenges: A Para Cyclist’s Journey .
In the latest episode of the Retinal Realities Podcast, Gavin and Karen sit down with Joel Zeijlstra, one of.